Male Breast Cancer Completed Phase Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01153672Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyTreatment